Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

주식 순위 #3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
주가
$32.32
시가총액
$5.33B
변동 (1일)
-3.01%
변동 (1년)
47.99%
국가
IN
거래 Gland Pharma Limited (GLAND)

카테고리

Healthcare
Gland Pharma Limited (GLAND)의 발행 주식 수
June 2026 기준 발행 주식 수: 164.83M
Gland Pharma Limited의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 164.83M입니다. March 2024 말 기준 회사는 164.74M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Gland Pharma Limited (GLAND)의 발행 주식 수 기록 (2017 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 164.83M 0.05%
2025 164.75M 0.00%
2024 164.74M 0.04%
2023 164.67M 0.08%
2022 164.54M 3.96%
2021 158.27M 2.15%
2020 154.95M -0.01%
2019 154.96M 0.01%
2018 154.95M 0.00%
2017 154.95M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수